Wenyu Feng

826 total citations
45 papers, 415 citations indexed

About

Wenyu Feng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenyu Feng has authored 45 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Wenyu Feng's work include Bone Metabolism and Diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Wenyu Feng is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Wenyu Feng collaborates with scholars based in China, Australia and United States. Wenyu Feng's co-authors include Shijie Liao, Jiake Xu, Yun Liu, Yun Liu, Jinmin Zhao, Qingjun Wei, Qingjun Wei, Tianyu Xie, Ziyi Wang and Xixi Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Wenyu Feng

39 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyu Feng China 13 230 112 92 84 75 45 415
Wenhua Yuan China 9 147 0.6× 102 0.9× 48 0.5× 82 1.0× 51 0.7× 20 315
Haifeng Wei China 15 289 1.3× 212 1.9× 87 0.9× 50 0.6× 60 0.8× 24 548
Jian‐Ching Wu Taiwan 12 260 1.1× 111 1.0× 74 0.8× 32 0.4× 56 0.7× 18 472
Carlos Resende Portugal 12 258 1.1× 129 1.2× 85 0.9× 71 0.8× 59 0.8× 25 559
Xiang Ding China 12 141 0.6× 51 0.5× 66 0.7× 50 0.6× 122 1.6× 25 469
Qishun Geng China 11 232 1.0× 108 1.0× 86 0.9× 55 0.7× 58 0.8× 28 382
Maryam Qasim Mohammed Iraq 6 166 0.7× 112 1.0× 81 0.9× 99 1.2× 37 0.5× 18 360
Changliang Peng China 14 297 1.3× 123 1.1× 103 1.1× 93 1.1× 32 0.4× 27 482
Zhe Jin China 13 292 1.3× 185 1.7× 47 0.5× 74 0.9× 43 0.6× 29 461

Countries citing papers authored by Wenyu Feng

Since Specialization
Citations

This map shows the geographic impact of Wenyu Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyu Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyu Feng more than expected).

Fields of papers citing papers by Wenyu Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyu Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyu Feng. The network helps show where Wenyu Feng may publish in the future.

Co-authorship network of co-authors of Wenyu Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyu Feng. A scholar is included among the top collaborators of Wenyu Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyu Feng. Wenyu Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Tianyu, Wenyu Feng, Liang Xiong, et al.. (2025). Single-cell RNA and bulk sequencing analysis reveals that formononetin inhibits GTSF1 to exert anti-osteosarcoma effects. APL Bioengineering. 9(3). 36110–36110.
3.
6.
Wang, Wei, Kun Wang, Jingquan Zhao, et al.. (2024). Identification and treatment of intestinal malrotation with midgut volvulus in childhood: a multicenter retrospective study. Frontiers in Pediatrics. 12. 1390856–1390856.
7.
Tang, Haijun, Chen Lin, Kai Luo, et al.. (2023). Association of survivin positive circulating tumor cell levels with immune escape and prognosis of osteosarcoma. Journal of Cancer Research and Clinical Oncology. 149(15). 13741–13751. 4 indexed citations
8.
Yu, Zhenyuan, Cheng Su, Wenhao Lu, et al.. (2023). Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma. Cancer Research. 83(5). 700–719. 45 indexed citations
9.
Luo, Xiaoting, Kai Luo, Shangyu Liu, et al.. (2023). Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma. Cancer Science. 114(7). 3014–3026. 15 indexed citations
10.
Ma, Yue, Xuejun Chai, Xiao Feng, et al.. (2023). Ketogenic diet attenuates cognitive dysfunctions induced by hypoglycemia via inhibiting endoplasmic reticulum stress-dependent pathways. Food & Function. 15(3). 1294–1309. 8 indexed citations
11.
Liu, Yun, Shijie Liao, Wenyu Feng, et al.. (2023). Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy. Heliyon. 10(1). e23601–e23601. 4 indexed citations
12.
Huang, Qian, Haijun Tang, Kai Luo, et al.. (2022). Circ_0001060 Upregulates and Encourages Progression in Osteosarcoma. DNA and Cell Biology. 42(1). 53–64. 2 indexed citations
13.
Feng, Wenyu, Dezhi Song, Hengyuan Li, et al.. (2022). Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma. Experimental Biology and Medicine. 247(14). 1214–1227. 22 indexed citations
14.
Qin, Zhaojie, Kai Luo, Yun Liu, et al.. (2022). ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing. SHILAP Revista de lepidopterología. 7 indexed citations
15.
Feng, Wenyu, Dezhi Song, Qingjun Wei, et al.. (2022). Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis. Experimental Biology and Medicine. 247(11). 921–930. 11 indexed citations
16.
Huang, Qian, Yun Liu, Chong Liu, et al.. (2022). Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss. Frontiers in Pharmacology. 13. 870553–870553. 5 indexed citations
17.
He, Juliang, Wenyu Feng, Xianxiang Chen, et al.. (2022). The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma. Scientific Reports. 12(1). 8756–8756. 7 indexed citations
18.
Liao, Shijie, Wenyu Feng, Xiaofei Ding, et al.. (2019). Rhoifolin ameliorates titanium particle‐stimulated osteolysis and attenuates osteoclastogenesis via RANKL‐induced NF‐κB and MAPK pathways. Journal of Cellular Physiology. 234(10). 17600–17611. 24 indexed citations
19.
Li, Jia, et al.. (2019). Gö6983 attenuates breast cancer‐induced osteolysis by the apoptotic pathway. Cell Biology International. 44(3). 838–847. 4 indexed citations
20.
Wang, Hongtao, Jia Li, Wenyu Feng, et al.. (2018). A study on the prevention and treatment of murine calvarial inflammatory osteolysis induced by ultra‑high‑molecular‑weight polyethylene particles with neomangiferin. Experimental and Therapeutic Medicine. 16(5). 3889–3896. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026